Candriam Luxembourg S.C.A. »

Foghorn Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 314k 4.78

More positions owned by Candriam Luxembourg S.C.A.

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Alphabet Cap Stk Cl C (GOOG)
Gilead Sciences (GILD)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
McKesson Corporation (MCK)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Palo Alto Networks (PANW)

View all positions for Candriam Luxembourg S.C.A.

Top funds holding Foghorn Therapeutics

Flagship Ventures Management
BVF
FMR
Deerfield Management Company
Raymond James Financial
BlackRock
Vanguard Group
Euclidean Capital
Vanguard Capital Management
Geode Capital Management
Siren
State Street Corporation
Ameriprise Financial
Candriam Luxembourg S.C.A.
Jacobs Levy Equity Management

View all funds holding Foghorn Therapeutics